Genotyping Market Is Predicted To Reach $37.1 Billion By 2024: Grand View Research, Inc.

Posted on 2019-01-03 by researchinsights in Biotech, Healthcare // 0 Comments

San Francisco, United States, 2019-Jan-03 — /EPR Network/ —The global genotyping market is expected to reach USD 37.1 billion by 2024 according to a new report by Grand View Research, Inc. The increasing demand for genotyping tests to evaluate drug efficacy and safety is one of the major drivers for the genotyping market. Genotyping tests are widely used in selecting a highly responsive, patient population subset against a specific drug candidate before initiating clinical trials. The rising need for affordable genotyping services coupled with the high demand for personalized medicines is also expected to propel the market growth.

Major pharmaceutical companies are collaborating with diagnostic manufacturers for the development of novel biomarker-based therapeutics. Significant opportunities for the growth of this market are anticipated due to the above-mentioned collaborative initiatives.

The increasing awareness for prenatal genetic testing pertaining to early detection of chromosomal abnormalities in the high-risk population, the introduction of technological advancements, and the increasing R&D funding are the other factors accentuating the market growth over the forecast period.

To request a sample copy or view summary of this report:
www.grandviewresearch.com/industry-analysis/genotyping-market

U.S. Genotyping market, by product, 2013 – 2024 (USD Million)

Further key findings from the report suggest:

The reagents and kits segment dominated the product segment in 2015. Extensive usage of reagents for research activities and the wide applicability of the genotyping tests in disease diagnosis and validation are the factors responsible for its large share
The reagent and kits segment is also anticipated to witness the highest growth over the forecast period. The major factors responsible for the lucrative growth of this segment are a high amount of R&D activities undertaken by research and academic institutes for the development of novel genetic biomarkers.
In 2015, the polymerase chain reaction technology captured a significant market share owing to the higher acceptance levels by researchers and the introduction of technologically advanced and user-friendly products
The diagnostic center was one of the largest segments with a market share of over39.0% in 2015. The rising demand for genotyping tests coupled with the high awareness for genetic disorders is a key driver for its large market share. Personalized medicine is expected to grow at a significant growth rate over the forecast period due to the increasing demand for the efficient and fast-acting therapeutics under the precision medicine category.
North America held the largest share of thegenotyping market in 2015.The rising healthcare expenditure, established R&D infrastructure, and the increasing awareness among doctors for hereditary genetic disorders are the factors contributing to the large share.
Asia Pacific is anticipated to be the fastest growing regional segment during the forecast period. The introduction of favorable government initiatives and programs, the geographical expansion of major players in this area, and the growing target population base are some of the factors expected to push forward the market growth.
The key players include Affymetrix, Inc., Agilent Technologies, Inc., Genewiz, Inc., Fluidigm Corporation, GE Healthcare GmbH, Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen NV, and Roche Diagnostics
In April 2016, Siemens Healthcare GmbH and Thermo Fisher Scientific, Inc. declared a strategic collaboration for the development of an advanced and integrated genotyping platform. This agreement aimed to introduce enhanced flexibility and customizability to their molecular testing solutions.

Related Report of Biotechnology:

Grand View Research has segmented the genotyping market on the basis of product, technology, application, and region:

Genotyping Market Product Outlook, by Revenue (USD Million, 2013 – 2024)

Instruments
Reagents and kits
Services

Genotyping Market Technology Outlook, by Revenue (USD Million, 2013 – 2024)

Polymerase Chain Reaction(PCR)
Capillary Electrophoresis
Mass Spectrometry
Sequencing
Microarray
Other

Genotyping Market Application Outlook, by Revenue (USD Million, 2013 – 2024)

Diagnostics
Drug Discovery and Development
Personalized Medicine
Academic Research
Agriculture
Others

Genotyping Market Regional Outlook, by Revenue (USD Million, 2013 – 2024)

North America
- U.S.
- Canada
Europe
- UK
- Germany
Asia Pacific
- Japan
- China
Latin America
- Brazil
MEA
- South Africa

Access Press Release Of This Research Report by Grand View Research: www.grandviewresearch.com/press-release/global-genotyping-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Matched content

Editor’s pick